Saturday, November 23, 2024
HomeTagsLMN-201

LMN-201

Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials

Lumen Bioscience a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced it was awarded $16.2 million by the U.S. Department of Defense...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics